HappeningToo topic
Enzalutamide reports
Browse community reports connected to Enzalutamide. These reports can show that other people are describing similar experiences, but they do not prove that Enzalutamide caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
39 problems
Abdominal Discomfort while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and abdominal discomfort appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and abdominal pain upper appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and abdominal pain appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and alopecia appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and anxiety appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and back pain appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and constipation appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and cough appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and decreased appetite appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and dehydration appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and diarrhea appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and dizziness appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and dyspepsia appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and excessive sweating appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and fatigue appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and feeling abnormal appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and headache appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hot Flush while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and hot flush appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and hypotension appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and insomnia appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and itching appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and malaise appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and muscle spasms appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and muscular weakness appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and myalgia appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and nausea appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and pain appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and peripheral swelling appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and rash appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and shortness of breath appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and sleepiness appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Taste changes while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and taste changes appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and tingling or pins and needles appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and tremor appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and vision blurred appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and vomiting appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and weakness appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and weight decreased appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Enzalutamide
FDA FAERS contains adverse-event reports in which Enzalutamide and weight increased appear together. This does not establish that Enzalutamide caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →